Anpac Bio Medical Science Co Ltd
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $15.87 million
- Book Value:
- Revenue TTM:
- $15.91 million
- Operating Margin TTM:
- Gross Profit TTM:
- $12.25 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Anpac Bio Medical Science Co Ltd had its IPO on 2020-01-30 under the ticker symbol ANPC.
The company operates in the Healthcare sector and Biotechnology industry. Anpac Bio Medical Science Co Ltd has a staff strength of 89 employees.
Shares of Anpac Bio Medical Science Co Ltd opened at $6.21 at the start of the last trading session i.e. 2023-03-23.
The stocks traded within a range of $5.66 - $7.75, and closed at $6.72.
This is a +13.8% increase from the previous day's closing price.
A total volume of 16,343 shares were traded at the close of the day’s session.
In the last one week, shares of Anpac Bio Medical Science Co Ltd have slipped by -13.04%.
Anpac Bio Medical Science Co Ltd's Key Ratios
Anpac Bio Medical Science Co Ltd has a market cap of $15.87 million, indicating a price to book ratio of 5.6732 and a price to sales ratio of 0.412.
In the last 12-months Anpac Bio Medical Science Co Ltd’s revenue was $15.91 million with a gross profit of $12.25 million and an EBITDA of $-73711504. The EBITDA ratio measures Anpac Bio Medical Science Co Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Anpac Bio Medical Science Co Ltd’s operating margin was -491.45% while its return on assets stood at -69.81% with a return of equity of -2985.73%.
In Q3, Anpac Bio Medical Science Co Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 44.5%.
Anpac Bio Medical Science Co Ltd’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-12.8 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Anpac Bio Medical Science Co Ltd’s profitability.
Anpac Bio Medical Science Co Ltd stock is trading at a EV to sales ratio of 0.5223 and a EV to EBITDA ratio of -0.0899. Its price to sales ratio in the trailing 12-months stood at 0.412.
Anpac Bio Medical Science Co Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $66.48 million
- Total Liabilities
- $56.15 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Anpac Bio Medical Science Co Ltd ended 2023 with $66.48 million in total assets and $0 in total liabilities. Its intangible assets were valued at $66.48 million while shareholder equity stood at $-3336000.00.
Anpac Bio Medical Science Co Ltd ended 2023 with $0 in deferred long-term liabilities, $56.15 million in other current liabilities, 2729000.00 in common stock, $-545635000.00 in retained earnings and $0.00 in goodwill. Its cash balance stood at $7.58 million and cash and short-term investments were $7.58 million. The company’s total short-term debt was $1,068,000 while long-term debt stood at $0.
Anpac Bio Medical Science Co Ltd’s total current assets stands at $37.02 million while long-term investments were $855000.00 and short-term investments were $0. Its net receivables were $10.77 million compared to accounts payable of $5.30 million and inventory worth $384000.00.
In 2023, Anpac Bio Medical Science Co Ltd's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Anpac Bio Medical Science Co Ltd paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Anpac Bio Medical Science Co Ltd stock is currently trading at $6.72 per share. It touched a 52-week high of $16.9 and a 52-week low of $16.9. Analysts tracking the stock have a 12-month average target price of $8.
Its 50-day moving average was $8.31 and 200-day moving average was $5.49 The short ratio stood at 0.85 indicating a short percent outstanding of 0%.
Around 721.8% of the company’s stock are held by insiders while 33.1% are held by institutions.
Frequently Asked Questions About Anpac Bio Medical Science Co Ltd
Similar Industry Stocks (Biotechnology)
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People’s Republic of China.